Clincial investigators

This pivotal multi-center international HEAT study intends to be one of the largest RFA studies ever
executed and will involve approximately 600 patients from North America, Europe and Asia.

The multi-center DIGNITY study is the first pivotal clinical study evaluating a chemotherapeutic agent in combination with hyperthermia for Recurrent Chest Wall (RCW) Disease in Breast Cancer.



Copyright © 2012 Celsion Corporation. Home  |  Privacy Policy  |  Governance  |  Media  |  Site Map